StockData

Rocket Pharmaceuticals vs Rocket One

RCKT and RKTO side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How RCKT and RKTO compare

Rocket Pharmaceuticals is the larger company, worth 29 times as much as Rocket One ($232M against $7.9M).

Rocket One scores higher on the StockData Score (6 against 3 for Rocket Pharmaceuticals), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricRCKTRKTO
Size and price
Market cap$232M$7.9M
Share price$2.11$0.317
Change, 1 year−30.8%−73.4%
Change, 5 years−91.1%−98.5%
Beta (5Y)2.321.84
Employees2022
StockData Score
Total score36 (better)
Valuation score11
Growth score00
Performance score1 (better)0
Health score15 (better)
Dividend score00
Valuation
P/B0.6× (better)1.0×
FCF yield−73.6%–
Profitability
Return on equity−4.8% (better)−148%
Return on invested capital−180% (better)−2004%
Financial health
Debt / equity–0.00
Interest coverage−101.3×–
Current ratio9.24 (better)6.20
Altman Z-score−2.72 (better)−11.81
Piotroski F-score12 (better)
Dividends and buybacks
Buyback yield–−107%
Shareholder yield0.00% (better)−107%
Ownership
Held by institutions90.9%6.5%
Held by insiders22.3%2.3%
Insider net buying, 12 months−$934K–
Short interest, % of float19.0%2.8%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.